Five Prime Therapeutics Overview

Five Prime Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for FPRX.

Quarterly EBIT

-$20.85M

↑ 33.5% YoY

As of Dec 31, 2020

Annual EBIT (TTM)

-$90.96M

↑ 33.71% YoY

Trailing 12 months ending Dec 31, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin